Trial Profile
A Double-blind, Placebo-controlled, Randomized First-in Human study of safety, tolerability and pharmacokinetics of ascending multiple oral doses of NA-831 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Oct 2018
Price :
$35
*
At a glance
- Drugs Traneurocin (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; First in man; Pharmacokinetics
- 04 Oct 2018 New trial record